<unk> is a chemotherapy regimen most often used as an induction or consolidation regimen in acute myelogenous leukemia, especially in poor-risk patients or those refractory to the standard first-line induction with standard "7+3" regimen or who<unk> relapsed after the standard chemotherapy.<unk> regimen consists of three drugs: # Ara-C (cytarabine) - an antimetabolite; # Daunorubicin - an anthracycline antibiotic that is able to intercalate DNA and thus disrupt the cell division cycle, preventing mitosis; # Etoposide - a topoisomerase inhibitor.
ADE 
ICE 
CAPOX
NLM
TOFI
ANCIC 
ADINA
AURA